Trying my best to translate new deal. Correct me if I'm wrong. Owcp entered into a deal with a non U.S. based investor through Newbridge. Newbridge was paid some kind of monetary fee + rights to purchase 2.5 million shares lower then the conversion rate to protect from dilution. Owcp issued 1000 new preferred shares of which 500 of those shares were given to the new unknown investor + rights to purchase an additional 12,500,00 common shares for a lower conversion rate. Note: 500 preferred shares equal 37,500,000 common shares. Owcp have 9 months (until the end of the year to pay back half of the preferred stock issued. They also have to pay the unknown investor quarterly payments of I believe $250,000 in cash or rights to purchase common stock. However, there are restrictions to purchasing common shares in regards to conversion from preferred shares to common shares. What's interesting is owcp issued 1,000 new preferred shares and only 500 were used. So here is my question, what are they doing with the remaining 500 preferred shares and could there be another possible deal/investor about to get involved? Another question is where are they getting $250,000 every 3 months to pay this unknown investor? We do not currently have any revenue so what is in the making right now? Either we are majorly screwed or they have a BIG announcement coming! Again, if I misinterpreted the 8k in any way I apologize and welcome feedback. I am merely trying to shed light on where we are currently and what may be to come.
(0)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links